Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth ... of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe proposed by ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

On Tuesday, the agency gave the green light for Ozempic to help protect kidney function in people with diabetes and Zepbound as the first-ever drug treatment for sleep apnea in people with obesity.

Then he started taking Ozempic, the Novo Nordisk diabetes drug that is sold under the name Wegovy for obesity. He later switched to Mounjaro, from Eli Lilly, which is sold as Zepbound for obesity.

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen ... the active ingredients in Wegovy and Zepbound, respectively. This study adds to a growing body of research documenting ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Physicians have warned that a small percentage of patients taking the popular weight loss and diabetes medications Ozempic, Wegovy, Mounjaro, and Zepbound have experienced vision loss. However ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why ...